Adam Dahlen, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 200 Se Hospital Ave, Stuart, FL 34994 Phone: 772-223-5618 Fax: 772-288-5834 |
Robert J Vanvliet, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 200 Se Hospital Ave, Stuart, FL 34994 Phone: 772-223-5618 Fax: 772-288-5834 |
Yale Tiley, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 200 Se Hospital Ave, Stuart, FL 34994 Phone: 772-278-5200 |
Kenson Lacossiere, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 200 Se Hospital Ave, Stuart, FL 34994 Phone: 772-223-5618 Fax: 772-288-5834 |
Maya Antony, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 200 Se Hospital Ave # 2346, Stuart, FL 34994 Phone: 772-287-5200 |
Dr. Sowande Buckmire, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 200 Se Hospital Ave, Stuart, FL 34994 Phone: 772-223-5618 Fax: 772-288-5834 |
Luis Felipe Duarte, M.D/PH.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 200 Se Hospital Ave, Stuart, FL 34994 Phone: 772-223-5618 Fax: 772-288-5834 |
Vijay B Thumma, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 200 Se Hospital Ave, Stuart, FL 34994 Phone: 772-223-5618 Fax: 772-288-5834 |
News Archive
Vietnam's largest tech firm, FPT, on Sunday announced it had dedicated its 2,000-room university dormitory as a quarantine site and US$850,000 in medical supplies to support the Government's fight against coronavirus (COVID-19).
A new study will be examining the implications of when and how NHS healthcare professionals re-contact patients with new genetic information that may impact their health or that of their family. The three year Economic and Social Research Council funded research will also explore issues of consent and how genetic information is stored.
For the 250,000 Canadians living with type 1 diabetes, the days of desperately trying to keep their blood sugar stable are coming to an end.
Cell Therapeutics, Inc. today announced the closing of its previously announced sale of 15,000 shares of its Series 18 Preferred Stock directly to Quogue Capital LLC and an affiliate of Perceptive Advisors LLC in a registered direct offering conducted without an underwriter or placement agent for gross proceeds of approximately $15 million (the "Offering").
› Verified 5 days ago